NOTA:FRA
Novartis AG
136,00 €
arrow_upward
+0,74%(+1,00) 1 p
21. okt, 08:49:52 GMT +2 · EUR
search
Kõik sümbolid
| Sümbol | Hind | Muutus | % muutus |
|---|
insights_autoÜksuse NOTA põhistatistika genereerimine…
Ava
136,00 €
Kõrge
136,00 €
Madal
136,00 €
Turu kapit.
257,56 mld
Keskm. maht
30,00
Maht
0,00
52 näd kõrgeim
145,00 €
52 näd madalaim
102,50 €
Töötajate arv
75 tuh
Ava
136,00 €
Kõrge
136,00 €
Madal
136,00 €
Turu kapit.
257,56 mld
Keskm. maht
30,00
Maht
0,00
52 näd kõrgeim
145,00 €
52 näd madalaim
102,50 €
Töötajate arv
75 tuh
Uudised
Veebiallikatest ja uudistepartneritelt
Investing.com Nigeria
·
1 päeva eest
Novartis ends Fabhalta trial for lupus kidney disease By Investing.com
24/7 Wall St.
·
1 kuu eest
Amgen Falls 10% as Novartis Trial Failure Clouds a Cholesterol Drug Class; NVS Stock Drops 14%
Profiil
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.
Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others.
Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes.
After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia
Teave üksuse Novartis AG kohta
TegevjuhtVasant Narasimhan
Töötajad75,3 tuh
Asutatud7. märts 1996
PeakontoridBasel, Basel, Šveits
Sektor-
Veebisaitnovartis.com